The researchers see the most immediate applications for this technology as involving the modeling of two to four organs, and are are now developing a model system for Parkinson's disease that includes brain, liver, and gastrointestinal tissue. Other applications, says Griffith, include modeling tumors that metastasize to other parts of the body.
"An advantage of our platform is that we can scale it up or down and accommodate a lot of different configurations," Griffith says. "I think the field is going to go through a transition where we start to get more information out of a three-organ or four-organ system, and it will start to become cost-competitive because the information you’re getting is so much more valuable."
'Body-on-a-Chip' system promises faster testing of new drugs
Medtechs: Fusing physical, digital & biological is 'current imperative'
Alternative to electronics; analyst forecasts growth in microfluidics
Lego-inspired microfluidics platform promotes mass production
Drug delivering micro 'robots' treat stomach infections